Location History:
- Dublin, CA (US) (2019)
- Madison, WI (US) (2023)
Company Filing History:
Years Active: 2019-2023
Title: Diana Jin Wang: Innovator in JAK Inhibitor Compounds
Introduction
Diana Jin Wang is a prominent inventor based in Dublin, CA (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that act as inhibitors of JAK kinases. With a total of 2 patents to her name, her work is paving the way for new treatments for gastrointestinal inflammatory diseases.
Latest Patents
Diana's latest patents include innovative compounds that target JAK3, a specific type of JAK kinase. The first patent, titled "Fused pyrimidine pyridinone compounds as JAK inhibitors," discloses compounds that are effective in treating gastrointestinal inflammatory diseases. The second patent, "Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors," also focuses on JAK3 inhibitors and includes pharmaceutical compositions and methods for their use in treating various inflammatory diseases.
Career Highlights
Diana is currently employed at Theravance Biopharma R&D IP, LLC, where she continues to advance her research in the pharmaceutical field. Her work is characterized by a commitment to developing effective treatments for complex health issues.
Collaborations
Diana collaborates with notable colleagues, including Erik Fenster and Tom M Lam, who contribute to her research efforts and the development of her innovative compounds.
Conclusion
Diana Jin Wang is a trailblazer in the field of pharmaceutical innovation, with her patents representing significant advancements in the treatment of inflammatory diseases. Her contributions are vital to the ongoing research and development in this important area of medicine.